Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRent ExpenseResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avricore Health (AVCRF) Revenue (2016 - 2025)

Avricore Health has reported Revenue over the past 11 years, most recently at $23987.3 for Q4 2025.

  • Quarterly Revenue fell 97.64% to $23987.3 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $374578.5 through Dec 2025, down 89.27% year-over-year, with the annual reading at $382112.2 for FY2025, 89.07% down from the prior year.
  • Revenue was $23987.3 for Q4 2025 at Avricore Health, down from $27379.6 in the prior quarter.
  • Over five years, Revenue peaked at $1.0 million in Q4 2024 and troughed at $4018.0 in Q2 2021.
  • The 5-year median for Revenue is $355250.3 (2025), against an average of $393710.0.
  • Year-over-year, Revenue soared 3339.05% in 2022 and then tumbled 97.64% in 2025.
  • A 5-year view of Revenue shows it stood at $27917.5 in 2021, then surged by 2478.78% to $719931.9 in 2022, then soared by 38.19% to $994857.1 in 2023, then rose by 2.25% to $1.0 million in 2024, then tumbled by 97.64% to $23987.3 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Revenue are $23987.3 (Q4 2025), $27379.6 (Q3 2025), and $20707.4 (Q2 2025).